Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals

Avian Diseases

Volumn 51, Issue 3, 2007, Pages 697-704

  Swayne, David E ^a   Avellaneda, Gloria ^a   Mickle, Thomas R ^b   Pritchard, Nikki ^b   Cruz, Julio ^b   Bublot, Michel ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Avian influenza; DIVA; Fowlpox virus; Hemagglutinin; Serology; Vaccine

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

AGAR GEL ELECTROPHORESIS; ANIMAL; ANIMAL DISEASE; ARTICLE; AVIAN INFLUENZA; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FOWLPOX VIRUS; GENETICS; GERMFREE ANIMAL; HEMAGGLUTINATION TEST; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; PHYLOGENY;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; ELECTROPHORESIS, AGAR GEL; FOWLPOX VIRUS; HEMAGGLUTINATION TESTS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; PHYLOGENY; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; FOWLPOX VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 34748899512     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/0005-2086(2007)51[697:ITTHIT]2.0.CO;2     Document Type: Article

References (28)

1. Barbeito, M. S., G. Abraham, M. Best, P. Cairns, P. Langevin, W. G. Sterritt, D. Barr, W. Meulepas, J. M. Sanchez-Vizcaino, M. Saraza, E. Requena, M. Collado, P. Mani, R. Breeze, H. Brunner, C. A. Mebus, R. L. Morgan, S. Rusk, L. M. Siegfried, and L. H. Thompson. Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. Rev. Sci. Tech. Off. Int. Epiz. 14:873-887. 1995.
2. Beard, C. W., W. M. Schnitzlein, and D. N. Tripathy. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 35:356-359. 1991.
3. Burrows, R., P. R. Spooner, and D. Goodridge. A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation. Dev. Biol. Stand. 39:341-346. 1977.
4. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, and J. F. Rodriguez. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 32:47-55. 2003.
5. Davenport, F. M., R. Rott, and W. Schafer. Physical and biological properties of influenza virus components obtained after ether treatment. J. Exp. Med. 112:765-783. 1960.
6. Fouchier, R. A. M., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. M. E. Osterhaus. Characterization of a novel influenza a virus hemagglutinin subtype (h16) obtained from black-headed gulls. J. Virol. 79:2814-2822. 2005.
7. Halvorson, D. A. Avian influenza control in Minnesota. Poult. Dig. 54:12-19. 1995.
8. Kendal, A. P., and T. R. Cate. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J. Clin. Microbiol. 18:930-934. 1983.
9. Kumar, S., S. Tamura, and M. Nei. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Briefings in Bioinformatics 5:150-163. 2006.
10. Monto, A. S., and H. F. Maassab. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J. Clin. Microbiol. 13:54-57. 1981.
11. Norrby, E. Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests. Proc. Soc. Exp. Biol. Med. 111:814-818. 1962.
12. Qiao, C. L., K. Z. Yu, Y. P. Jiang, Y. Q. Jia, G. B. Tian, M. Liu, G. H. Deng, X. R. Wang, Q. W. Meng, and X. Y. Tang. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32:25-31. 2003.
13. Saitou, N., and M. Nei. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425. 1987.
14. Stone, H. D. Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avian Dis. 31:483-490. 1987.
15. Swayne, D. E. Application of new vaccine technologies for the control of transboundary diseases. Dev. Biologicals 119:219-228. 2004.
16. Swayne, D. E., J. R. Beck, M. Garcia, and H. D. Stone. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol. 28:245-255. 1999.
17. Swayne, D. E., J. R. Beck, and N. Kinney. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44:132-137. 2000.
18. Swayne, D. E., J. R. Beck, and T. R. Mickle. Efficacy of recombinant fowl pox vaccine in protecting chickens against highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis. 41:910-922. 1997.
19. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095. 2000.
20. Swayne, D. E., and D. A. Halvorson. Influenza. In: Diseases of poultry, 11th ed. Y. M. Saif, H. J. Barnes, A. M. Fadly, J. R. Glisson, L. R. McDougald, and D. E. Swayne, eds. Iowa State University Press, Ames, IA. pp. 135-160. 2003.
21. Swayne, D. E., C. W. Lee, and E. Spackman. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol. 35:141-146. 2006.
22. Swayne, D. E., D. A. Senne, and C. W. Beard. Influenza. In: Isolation and identification of avian pathogens, 4th ed. D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 150-155. 1998.
23. Taylor, J., R. Weinberg, Y. Kawaoka, R. G. Webster, and E. Paoletti. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6:504-508. 1988.
24. Thompson, J. D., D. G. Higgins, and T. J. Gibson. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680. 2006.
25. Tumpey, T. M., R. Alvarez, D. E. Swayne, and D. L. Suarez. A diagnostic aid for differentiating infected from vaccinated poultry based on antibodies to the nonstructural (NS1) protein of influenza A virus. J. Clin. Microbiol. 43:676-683. 2005.
26. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303-308. 1991.
27. Webster, R. G., J. Taylor, J. Pearson, E. Rivera, and E. Paoletti. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant. Avian Dis. 40:461-465. 1996.
28. Zhao, S., M. Jin, H. Li, Y. Tan, G. Wang, R. Zhang, and H. Chen. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens. Avian Dis. 49:488-493. 2005.